Albany Molecular Research Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Albany Molecular are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Albany Molecular Research has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Albany Molecular is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Target High Price | 10.70 | |
| Target Low Price | 10.70 |
Albany |
Albany Molecular Relative Risk vs. Return Landscape
If you would invest (100.00) in Albany Molecular Research on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Albany Molecular Research or generate -100.0% return on investment over 90 days. Albany Molecular Research is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Albany, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Albany Molecular Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Albany Molecular's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Albany Molecular Research, and traders can use it to determine the average amount a Albany Molecular's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AMRI |
Based on monthly moving average Albany Molecular is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Albany Molecular by adding Albany Molecular to a well-diversified portfolio.
Albany Molecular Fundamentals Growth
Albany Stock prices reflect investors' perceptions of the future prospects and financial health of Albany Molecular, and Albany Molecular fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Albany Stock performance.
| Return On Equity | -22.11 | |||
| Return On Asset | -0.0657 | |||
| Profit Margin | (11.94) % | |||
| Operating Margin | 0.87 % | |||
| Current Valuation | 981.79 M | |||
| Shares Outstanding | 42.7 M | |||
| Price To Earning | (15.32) X | |||
| Price To Book | 2.86 X | |||
| Price To Sales | 1.36 X | |||
| Revenue | 680.81 M | |||
| EBITDA | 73.33 M | |||
| Cash And Equivalents | 42.23 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 647.96 M | |||
| Debt To Equity | 204.30 % | |||
| Book Value Per Share | 9.92 X | |||
| Cash Flow From Operations | 19.91 M | |||
| Earnings Per Share | (1.42) X | |||
| Total Asset | 865.57 M | |||
| Retained Earnings | 120.65 M | |||
| Current Asset | 280.25 M | |||
| Current Liabilities | 99.1 M | |||
Things to note about Albany Molecular Research performance evaluation
Checking the ongoing alerts about Albany Molecular for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Albany Molecular Research help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Albany Molecular is not yet fully synchronised with the market data | |
| Albany Molecular has some characteristics of a very speculative penny stock | |
| Albany Molecular has a very high chance of going through financial distress in the upcoming years | |
| Albany Molecular has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company currently holds 647.96 M in liabilities with Debt to Equity (D/E) ratio of 204.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Albany Molecular Research has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Albany Molecular until it has trouble settling it off, either with new capital or with free cash flow. So, Albany Molecular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Albany Molecular Research sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Albany to invest in growth at high rates of return. When we think about Albany Molecular's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 680.81 M. Net Loss for the year was (59.77 M) with profit before overhead, payroll, taxes, and interest of 132.8 M. | |
| Over 97.0% of Albany Molecular shares are held by institutions such as insurance companies |
- Analyzing Albany Molecular's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Albany Molecular's stock is overvalued or undervalued compared to its peers.
- Examining Albany Molecular's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Albany Molecular's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Albany Molecular's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Albany Molecular's stock. These opinions can provide insight into Albany Molecular's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Albany Stock
If you are still planning to invest in Albany Molecular Research check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albany Molecular's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |